Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies

Journal of Virology

Volumn 74, Issue 21, 2000, Pages 10229-10235

  Singh, A ^a   Collman, R G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ARTICLE; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN VARIANT; SEQUENCE ANALYSIS; STRAIN DIFFERENCE;

AMINO ACID SEQUENCE; CLONING, MOLECULAR; GENE PRODUCTS, ENV; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMAN; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHYLOGENY; POLYMERASE CHAIN REACTION; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; SUPPORT, U.S. GOV'T, P.H.S.; VARIATION (GENETICS); VIRION;

EID: 0033775934     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.21.10229-10235.2000     Document Type: Article

References (37)

1. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
2. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
3. Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells
4. V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1
5. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism
6. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
7. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection
8. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immuno-deficiency virus type 1
9. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
10. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
11. A dual-tropic HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
12. An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus
13. Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency
14. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo
15. Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: Evidence for in vivo recombination and determinants of cytotropism outside the V3 domain
16. + lymphocyte depletion in rhesus monkeys
17. V3-independent determinants of macrophage tropism in a primary, human immunodeficiency virus type 1 isolate
18. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization
19. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
20. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain
21. Cell-dependent mechanisms restrict the HIV type 1 coreceptor activity of US28, a chemokine receptor homolog encoded by human cytomegalovirus
22. The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes
23. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
24. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses
25. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
26. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture
27. Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles
28. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry
29. Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood
30. Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate
31. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop
32. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: Studies on sequential HIV isolates
33. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1
34. Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates
35. Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: Therapeutic and prophylactic implications
36. Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D
37. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection